Sign Up Today and Learn More About Basecamp Research Stock
Invest in or calculate the value of your shares in Basecamp Research or other pre-IPO companies through EquityZen's platform.
Basecamp Research Stock (BASR)
Basecamp Research leverages their unprecedented knowledge of the natural world to create better medicines, better food and better products
About Basecamp Research Stock
Founded
2019
Industries
Software, Artificial Intelligence, Data and Analytics
Basecamp Research Press Mentions
Stay in the know about the latest news on Basecamp Research
EDEN: The AI ​​system that learns from a million species to design new treatments
english • Feb 27, 2026
Global Non-Specific Endonuclease Market Set to Nearly Double by 2036, Reaching USD 726.6 Million | TMR
einpresswire • Feb 18, 2026
Researchers from Nvidia, Microsoft, and others use AI on 1M+ species to generate potential new gene editing and drug therapies, including AI-designed enzymes (Financial Times)
techmeme • Jan 12, 2026
Nebius AI Cloud Deployed in UK with NVIDIA AI
insidehpc • Nov 08, 2025
Nebius AI Cloud arrives in UK with one of the country’s first advanced NVIDIA AI infrastructure deployments
marketscreener • Nov 06, 2025
Basecamp Research Management
Leadership team at Basecamp Research
Co-Founder
Glen Gowers
Co-Founder
Oliver Vince
Join now and verify your accreditation status to gain access to:
- Basecamp Research Current Valuation
- Basecamp Research Stock Price
- Basecamp Research Management
- Available deals in Basecamp Research and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Basecamp Research Cap Table and Funding History by Share Class and Liquidity Preferences
- Basecamp Research Revenue and Financials
- Basecamp Research Highlights
- Basecamp Research Business Model
- Basecamp Research Risk Factors
- Basecamp Research Research Report from SACRA Research
Trading Basecamp Research Stock
How to invest in Basecamp Research stock?
Accredited investors can buy pre-IPO stock in companies like Basecamp Research through EquityZen funds. These investments are made available by existing Basecamp Research shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.
How to sell Basecamp Research stock?
Shareholders can sell their Basecamp Research stock through EquityZen's private company marketplace. EquityZen's network includes over 430K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 52K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
